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Objective: This prospective randomized study sought to verify the systemic inflammatory response, inflamma-
tory myocardial damage, and early clinical outcome in coronary surgery with the miniaturized extracorporeal
circulation system or on the beating heart.
Methods: Sixty consecutive patients were randomized to miniaturized extracorporeal circulation (n ¼ 30) or
off-pump coronary revascularization (off-pump coronary artery bypass grafting, n¼ 30). Intraoperative and post-
operative data were recorded. Plasma levels of interleukin-6 and tumor necrosis factor-a were measured from
systemic blood intraoperatively, at the end of operation, and 24 and 48 hours thereafter. Levels of the same
markers and blood lactate were measured from coronary sinus blood intraoperatively to evaluate myocardial
inflammation. Markers of myocardial damage were also analyzed.
Results: One patient died in the off-pump coronary artery bypass grafting group. There was no statistical differ-
ence in early clinical outcome in both groups. Release of interleukin-6 was higher in the off-pump coronary artery
bypass grafting group 24 hours after the operation (P ¼ .03), whereas levels of tumor necrosis factor-a were not
different in both groups. Cardiac release of interleukin-6, tumor necrosis factor-a, and blood lactate were not dif-
ferent in both groups. Release of troponin T was not significantly different in both groups. Levels of creatine
kinase mass were statistically higher in the miniaturized extracorporeal circulation group than in the off-pump
coronary artery bypass grafting group, but only at the end of the operation (P< .0001). Hemoglobin levels
were significantly higher in the miniaturized extracorporeal circulation group than in the off-pump coronary artery
bypass grafting group after 24 hours (P ¼ .01).
Conclusion: Miniaturized extracorporeal circulation can be considered similar to off-pump surgery in terms of
systemic inflammatory response, myocardial inflammation and damage, and early outcome.
CARDIOPULMONARY SUPPORTSystemic inflammation response syndrome (SIRS) is the
main problem linked to the cardiopulmonary bypass (CPB),
and its pathogenesis is not well known. It is worth noticing
that the blood–air interface and the contact between the blood
and the artificial surfaces of the CPB circuit play an important
role in initiating SIRS. The inflammatory response is stimu-
lated by a large number of events that result in vascular and
tissue damage caused by leukocyte–endothelial interactions
mediated by the release of different cytokines, such as inter-
leukin (IL)-6 and tumor necrosis factor (TNF)-a. The clinical
manifestations of SIRS are several and may lead to consider-
able postoperative morbidity and mortality in some patients:
Coagulative disorders,1,2 myocardial damage,3 fluid reten-
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atively affect the postoperative course. Recent articles report
better results in off-pump coronary artery bypass grafting
(OPCABG) compared with CPB in terms of myocardial, re-
nal and cerebral organ preservation,10-14 and SIRS.15 How-
ever, OPCABG has some important drawbacks, such as
incomplete revascularization, low graft patency, and hemo-
dynamic instability occurring during the displacement of
the heart.16,17 New concepts in the management and materials
of CPB have been developed, and efforts are focused on
reducing tubing surface area, improving surface coating cir-
cuit, eliminating blood–air contact, using closed cardiotomy,
and improving oxygenators to obtain a low-risk CPB system.
The miniaturized extracorporeal circulation (MECC) sys-
tem should dramatically reduce the side effects caused by
CPB, thus resulting in a low inflammation response as for
OPCABG and allowing a complete myocardial revasculari-
zation as for standard CPB.
Many authors have already described the benefit of
MECC versus standard CPB in terms of reduced myocardial
damage, less coagulative disorder, and less inflammatory
response.18-21 On the other hand, few articles22,23 have re-
cently compared the MECC procedure with the OPCABG
procedure.rgery c May 2009
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SAbbreviations and Acronyms
CK ¼ creatine kinase
CPB ¼ cardiopulmonary bypass
CS ¼ coronary sinus
IL ¼ interleukin
MECC ¼ miniaturized extracorporeal circulation
OPCABG ¼ off-pump coronary artery bypass
grafting
SIRS ¼ systemic inflammation response
syndrome
TNF ¼ tumor necrosis factor
TnT ¼ troponin T
This prospective randomized study evaluated the systemic
inflammatory response, myocardial necrosis, and myocar-
dial inflammation by comparing patients with coronary ar-
tery disease who underwent operation with the MECC
system or on the beating heart. For this purpose, cytokines
such as IL-6 and TNF-a and biochemical measurements
from both systemic and coronary sinus (CS) blood were in-
traoperatively and postoperatively investigated.
MATERIALS AND METHODS
Patient Selection
FromApril 2007 to October 2007, 60 consecutive patients with coronary
disease whowere technically suitable forMECC or OPCABGwere enrolled
in this study after providing written informed consent. The patients were
randomly allocated into 2 groups: MECC (n ¼ 30) or OPCABG (n ¼
30). Inclusion criteria were as follows: primary and isolated CABG opera-
tion; at least 2-vessel disease; ejection fraction of 40% or more; 30 to 85
years of age; serum creatinine less than 1.8 mg/100 mL; and absence of
acute or chronic inflammatory syndrome. Exclusion criteria were as fol-
lows: small, calcified, and intramyocardial coronaries; recent or current ste-
roid treatments; urgent or salvage operation; recent myocardial infarction
(<10 days); unstable angina with intravenous medications; and conversion
of OPCABG to standard CPB during the operation. A randomization list
was generated by a computer algorithm. This prospective randomized study
was approved by the local ethics committee.
Sample Collection
Blood samples were collected to analyze 1) the myocardial damage: tro-
ponin T (TnT), myoglobin, total creatine kinase (CK), and CK mass; 2) the
inflammatory response: IL-6, TNF-a, C-reactive protein, leukocyte, neutro-
phil, and monocyte cell counts; 3) the hemodilution: hematocrit and haemo-
globin; and 4) the coagulative disorder: fibrinogen and platelet count. Blood
samples for myocardial damage, hemodilution, and coagulative disorder
were serially collected the day before surgery (T0), at the end of operation
(T1), 24 hours after operation (T2), and 48 hours after operation (T3). Blood
lactate and cytokine levels were analyzed before the anesthesia induction
(T0), before CPB initiation in the MECC group or before the first distal
anastomosis in the OPCABG group (T1), 5 minutes after aortic clamp re-
moval in the MECC group or 5 minutes after the last distal anastomosis
in the OPCABG group (T2), at the end of operation (T3), 12 hours after op-
eration (T4), and 24 hours after operation (T5). Blood lactate, IL-6, TNF-a,
hemoglobin, and hematocrit were analyzed by contemporaneously taking 2
blood samples from the radial artery and the CS before instituting CPB in
the MECC group or before the first distal anastomosis in the OPCABGThe Journal of Thoracic and Cgroup (T1) and 5 minutes after aortic clamp removal in the MECC group
or after the last distal anastomosis in the OPCABG group (T2). In both
groups, a CS cannula for cardioplegia delivery (Edwards Lifesciences,
Irvine, Calif) was used for taking the blood samples. In the MECC group,
the sinus cannula was kept inside the CS throughout the period of aortic
clamping, whereas in the OPCABG group the cannula was used for only
the blood sample collection.
Surgical Strategy
Anesthesia protocol was the same in all patients. Anesthesia was induced
with fentanyl 0.005 to 0.01 mg/kg, midazolam 0.08 to 0.2 mg/kg, and pan-
curonium 0.1 mg/kg, and was maintained with propofol 3 to 6 mg/kg/h, fen-
tanyl, sevoflurane, and pancuronium as needed.
All patients underwent operation via a full median sternotomy. The left
internal thoracic artery (ITA) was harvested in all patients and always
anastomosed on the left anterior descending artery. In those patients who
received both thoracic arteries, the right ITA was anastomosed on the
marginal branch. Total arterial revascularization was obtained with bilateral
ITAs and the left radial artery. Because pedicle thoracic arteries and the left
ITA on the left anterior descending artery are preferred to other alternatives
in our institution (Cardiac Surgery Clinic at San Gerardo Hospital), no
patients received composite grafts or right ITAs on the left anterior descend-
ing artery.
The MECC is a Bioline fully heparin-coated system that includes a cen-
trifugal pump Rotaflow RF-32 (Maquet-Jostra AG, Hirrlingen, Germany)
and a continuous diffusion polymethylpentene membrane oxygenator
Quadrox D with an integrated heat exchanger, (Maquet-Jostra AG, Hirrlin-
gen, Germany). The system did not include any cardiotomy, and the pericar-
dial shed blood was sucked into a cell saver device (CAIS Fresenius
Hemocare, Bad Homburg, Germany) that was also used in the OPCABG
group. An arterial filter Quart (Maquet-Jostra AG, Hirrlingen, Germany)
was positioned between the oxygenator and the arterial line to remove mi-
crobubbles; a venous bubble trap VBT 160 (Maquet-Jostra AG, Hirrlingen,
Germany) was allocated between the venous line and the centrifugal pump
to remove air bubbles coming from the vein line or the aortic root vent. The
system was primed with 1000 mL of Ringer’s lactate solution, 100 mL of
18%mannitol, and 500mL of 6% hydroxyethyl starch (Voluven, Fresenius
Kabi, Bad Homburg, Germany). The effective prime was approximately
650 mL. MECC was instituted by ascending aorta and right atrium cannu-
lation, and the management was as follows: a blood flow rate of 2.4 L/min/
m2 , mean systolic pressure ranging between 60 and 80 mm Hg, and corpo-
real temperature of 35C. Heparin was given at a dose of 3 mg/kg with an
activated clotting time ranging from 350 to 400 seconds. Cardiac arrest was
obtained through a cold (4C) intermittent blood cardioplegic solution in-
jected via the aortic root and CS. Cardioplegia maintenance was repeated
every 18 to 20 minutes. Protamine sulphate was given to neutralize the hep-
arin. The circuit was 3/8 size for all length, and the effective total length was
less than 1 m. All distal and proximal anastomoses were performed under
a single total aortic crossclamping time.
In the OPCABG group, heparin was given at a dose of 1.5 mg/kg with an
activated clotting time target of 250 seconds. The anastomosis between the
left ITA and the left anterior descending artery was always performed first,
and then the proximal anastomosis in the aortic root was performed with the
HeartString II Proximal Seal System device (Maquet AG, Hirrlingen, Ger-
many). The distal anastomosis on the marginal branches and right coronary
system was finally done. The heart was stabilized using the Medtronic Oc-
topus device (Medtronic, Minneapolis, Minn), and the marginal branches of
the left circumflex and right coronary arteries were exposed by a long strip
anchored to a deep pericardial stitch with a tourniquet. All operations were
performed by the same senior surgeon (F.F.).
Sample Storage
The samples for IL-6 and TNF-a were immediately cooled to 4C and
centrifuged at 5000 rpm for 20 minutes at 4C. The supernatant wasardiovascular Surgery c Volume 137, Number 5 1207
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Sseparated and stored at80C. IL-6 and TNF-a were measured by an en-
zyme-linked immunosorbent assay using a commercial kit (R&D System,
DuoSet ELISA, Minneapolis, Minn) with a minimum detectable dose of
5.0 pg/mL. Measurements of TnT, myoglobin, and CK-MB mass were
done using an Elecsys 2010 analyzer (Roche Diagnostics, Mannheim,
Germany). These assays are based on electrochemiluminescence immuno-
assay technology (Roche Diagnostics, Mannheim, Germany). The detection
limitwas0.01mg/L forTnT,15mg/L formyoglobin, and0.1mg/L forCKmass.
Statistical Analysis
Data are expressed as the mean standard deviation for continuous vari-
ables. The categoric variables are expressed as percentages. Unpaired t and
chi-square tests were applied to compare clinical variables. The Mann–
Whitney U test was used for those variables that were not normally distrib-
uted. Analysis of continues variables over time were analyzed by applying
the 2-way analysis of variance for repeatedmeasures. All data were prospec-
tively included in a statistical database and analyzed with the Statistical
Package for the Social Sciences (15.0 forWindows; SPSS Inc, Chicago, Ill).
RESULTS
Clinical Outcomes
No patient was withdrawn from the study. Preoperative
characteristics (Table 1) did not differ between groups. Peri-
operative and postoperative parameters (Table 2) were also
similar between groups except for the use of bilateral inter-
nal thoracic arteries, which was significantly lower in the
OPCABG group than in the MECC group. There was no sta-
tistical significance in both groups regarding postoperative
bleeding, requirement of blood transfusions, and incidence
of atrial fibrillation. One patient treated withMECC required
the use of an intraaortic balloon pump after weaning from
extracorporeal circulation because of a new onset of lateral
transmural ischemia despite the use of inotropic drugs and
a coronary vasodilator. The patient was supported with an
intra-aortic balloon pump for 48 hours and was discharged
on the ninth postoperative day. One patient in the OPCABG
group died of acute severe respiratory disease on the fifth
postoperative day. No patients had postoperative cerebro-
TABLE 1. Patient characteristics
Variables
MECC system
(n ¼ 30)
OPCABG
(n ¼ 30) P
Gender (male) 23 (76.6%) 18 (60%) .07
Mean age (y) 61.2  10.4 (35–76) 70  7.7 (56–83) .05
Ejection fraction (%) 57  7 (42–67) 56.4  9.2 (40–71) .08
Left main disease 12 (40%) 8 (26.6%) .50
Vessel disease 2.5  0.51 2.47  0.51 .30
BSA 1.85  0.16 1.76  0.21 .10
BMI 25.5  1.6 26.3  4.8 .80
Hyperlipidemia 21 (70%) 17 (56.6%) .50
Hypertension 17 (56.6%) 22 (73.3%) .10
Diabetes mellitus 7 (23.3%) 11 (36.6%) .60
Smoking 14 (60%) 9 (46.7%) .10
COPD 2 (6.6%) 4 (13.3%) .20
Carotid disease 2 (6.6%) 4 (13.3%) .20
BSA, Body surface area; BMI, body mass index; COPD, chronic obstructive pulmo-
nary disease; MECC, miniaturized extracorporeal circulation; OPCABG, off-pump
coronary artery bypass grafting.1208 The Journal of Thoracic and Cardiovascular Svascular accident, low cardiac output syndrome, or acute re-
nal failure.
Myocardial Damage
No patient experienced a new postoperative myocardial
infarction defined as new Q waves of more than 0.05 ms
and a reduction in R waves of more than 25% in at least 2
electrocardiogram leads, as well as new echocardiographic
akinesia or hypokinesia area. TnT and myoglobin increased
regularly over time without difference between the 2 groups.
TnT peaked at 24 hours and then decreased after 48 hours;
the myoglobin peak was recorded at the end of the operation
and decreased after. Levels of total CK and CK-mass serum
were statistically higher in the MECC group than in the OP-
CABG group, but only at the end of the operation (total CK:
204.5 103.1 U/L vs 143.4 79.9 U/L, P¼ .04; CK-mass:
15.7  5.2 mg/L vs 9.5  3.6 mg/L, P< .0001); the differ-
ence disappeared 24 and 48 hours after the operation.
Inflammatory Response
IL-6 plasma levels increased in both groups during and af-
ter the operation. IL-6 levels were significantly higher in the
OPCABG group than in the MECC group 24 hours after the
operation (P ¼ .03; Figure 1, A). TNF-a levels were higher
in the OPCABG group than in the MECC group at each time
point, although no statistical difference was recorded; more-
over, there was a decrease at the end of the operation in both
groups (Figure 1, B). Transmyocardial gradient was calcu-
lated by the difference between arterial and CS levels, and
the negative gradient was interpreted as the cardiac release
of cytokines into the coronary circulation. There were no
TABLE 2. Perioperative and postoperative data
Variables
MECC system
(n ¼ 30)
OPCABG
(n ¼ 30) P
No. of distal anastomoses 2.70  0.65 2.53  0.61 .30
BITAs 18 (60%) 5 (8.3%) .01
CPB time (min) 87.1  19 — —
Aortic crossclamping
time (min)
67.15  15.21 — —
Intubation time 10.4  6.9 10  3.2 .82
ICU stay (h) 27.65  23.2 25.37  15.1 .72
Bleeding within 12 h 426  246.48 414.21  198.58 .87
Reexploration for
bleeding/tamponade
0 0 1
IABP 1 (1.6%) 0 .81
Atrial fibrillation 12 (40%) 7 (23.3%) .3
Patients receiving
transfusion during
hospitalization
10 (33.3%) 11 (36.6%) .9
Hospital stay (d) 5.05  1.39 5.44  1.29 .39
Hospital mortality 0 1 (1.6%) .81
BITA, Bilateral internal thoracic artery; CPB, cardiopulmonary bypass; OR, operating
room; ICU, intensive cardiac unit; IABP, intra-aortic balloon pump;MECC, miniatur-
ized extracorporeal circulation; OPCABG, off-pump coronary artery bypass grafting.urgery c May 2009
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the 2 groups at T1. Cardiac release of IL-6 was higher in
the OPCABG group than in the MECC group at T2, but
without significant difference (Figure 2, A); at the same
time point, cardiac release of TNF-a was more evident in
the MECC group than in the OPCABG group, but without
significant difference (Figure 2, B). Monocyte cell levels de-
creased at the end of the operation and then increased 24 and
48 hours after the operation (Figure 3).
Hemodilution
Hemoglobin levels were significantly higher in theMECC
group than in the OPCABG group 24 hours after the opera-
FIGURE 1. A, Time course of IL-6 in patients undergoing OPCABG or
MECC. B, Time course of TNF-a in patients undergoing OPCABG or
MECC. T0¼ before CPB initiation in MECC group or before the first distal
anastomosis in OPCABG group; T1¼ 5 minutes after aortic clamp removal
in MECC group or 5 minutes after the last distal anastomosis in OPCABG
group; T2 ¼ end of operation; T3 ¼ 24 hours; T4 ¼ 48 hours. Data are ex-
pressed as means standard error of the mean (SEM). IL, Interleukin; TNF,
tumor necrosis factor.The Journal of Thoracic and Ction (P¼ .01; Table 2), despite the fact that no significant dif-
ference was observed between the groups in terms of the
number of patients receiving transfusion and the number of
red cell blood units transfused per patient at the same time
point. Although a statistical difference in arterial systemic he-
moglobin was observed in both groups 5 minutes after aortic
clamp removal in the MECC group and after the last distal
anastomosis in the OPCABG group (8.8  0.9 g/100 mL
vs 9.9 1.6 g/100mL,P¼ .012), no difference was reported
in CS hemoglobin in both groups at the same time (9 1.1 g/
100 mL vs 9.8  1.6 g/100 mL, respectively, P ¼ .09).
Systemic and Cardiac Blood Lactate
The time course of systemic blood lactate increased in
both groups during and after the operation. The blood lactate
FIGURE 2. A, Arteriovenous difference of IL-6-from CS in patients
undergoing OPCABG or MECC. B, Arteriovenous difference of TNF-a-
from CS in patients undergoing OPCABG or MECC. T0 ¼ before CPB
initiation in MECC group or before the first distal anastomosis in OPCABG
group; T1¼ 5 minutes after aortic clamp removal in MECC group or 5 min-
utes after the last distal anastomosis in OPCABG group. Data are expressed
as means  SEM. IL, Interleukin; TNF, tumor necrosis factor.ardiovascular Surgery c Volume 137, Number 5 1209
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there was no significant difference in the OPCABG group.
At 12 hours, the blood lactate release in the MECC group
was significantly lower than in the OPCABG group (P ¼
.009; Figure 4, A). Cardiac blood lactate from the CS
increased significantly in both groups intraoperatively
and showed higher levels in the MECC group than in the
OPCABG group, although no statistical differences were
detected (Figure 4, B).
DISCUSSION
The MECC system is a new concept of CPB that was re-
cently introduced into clinical practice.24 The main goal of
MECC was to create a simplified system to reduce the dele-
terious effects of conventional CPB.25 The MECC system
links the concept of increased biocompatibility using a hep-
arin-coated circuit with reduced air–blood interface, elimi-
nating the cardiotomy. Many authors have conducted
randomized studies comparing the MECC system with con-
ventional CPB in patients undergoing CABG. Fromes and
colleagues18 found a reduced inflammatory activation and
a lower S-100 protein release in the MECC group. Beghi
and colleagues26 reported no statistical difference in TnT
and IL-6 evolution in the MEEC group. Wiesenack and col-
leagues24 reported their 4 years of experience in using
MECC and showed a reduced incidence of postoperative
complications and a lower blood lactate release. The recent
experiences of many authors with MECC in patients under-
going CABG have been encouraging, and some have ex-
tended the MECC system in aortic valve replacement,
reporting reduced inflammatory response27 and better myo-
cardial protection.28
Few authors have compared MECC with OPCABG. In
a prospective randomized study of 150 patients per group,
Mazzei and coworkers23 demonstrated that the MECC and
OPCABG groups had similar IL-6, S-100 protein, and total
FIGURE 3. Time course of monocyte count in patients undergoing OP-
CABG or MECC. T0 ¼ preoperative; T1 ¼ end of operation; T2 ¼ 24
hours; T3 ¼ 48 hours. Data are expressed as means  SEM.1210 The Journal of Thoracic and Cardiovascular SuCK release. They assert that even if MECC is associated
with cardioplegic arrest, the 2 procedures could be consid-
ered equivalent in terms of myocardial and brain damage, in-
flammatory response, early mortality, and 1-year morbidity
and mortality.
To the best of our knowledge, there are no data published
on the myocardial inflammation in patients undergoing op-
eration with the MECC system measured by collecting
blood samples through the CS. Therefore, we wanted to ob-
serve whether the MECC system preserves myocardial in-
flammation and reduces ischemic/reperfusion injury by
measuring inflammatory cytokines (eg, IL-6 and TNF-a)
and lactate levels directly from the CS.
FIGURE 4. A, Time course of systemic blood lactate in patients undergo-
ing OPCABG or MECC. T0¼ before CPB initiation in MECC group or be-
fore the first distal anastomosis in OPCABG group; T1 ¼ 5 minutes after
aortic clamp removal in MECC group or 5 minutes after the last distal anas-
tomosis in OPCABG group; T2 ¼ end of operation; T3, ¼ 12 hours; T4 ¼
24 hours; T5 ¼ 48 hours. B, Time course of blood lactate from CS in pa-
tients undergoing OPCABG or MECC. T0 ¼ before CPB initiation in
MECC group or before the first distal anastomosis in OPCABG group;
T1 ¼ 5 minutes after aortic clamp removal in MECC group or 5 minutes
after the last distal anastomosis in OPCABG group. Data are expressed as
means  SEM.rgery c May 2009
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with detrimental systemic myocardium effects. IL-6 in-
creases in response to major surgeries, including cardiac sur-
gery with CPB, and is probably released by mononuclear
macrophages.18 TNF-a has a negative inotrope effect, and
the myocardium is probably the source of this inflammatory
cytokine after ischemia/reperfusion injury. A subset of ma-
ture blood monocyte cells are recognized as a major source
of TNF-a.29,30 We observed no significant differences be-
tween the 2 groups in terms of systemic and cardiac IL-6
and TNF-a release. Systemic blood TNF-a levels were
higher in the OPCABG group than in the MECC group dur-
ing and after the operation, but without statistic difference
over time. The lowest peak of TNF-a levels recorded in
both groups at the end of the operation should be considered
with regard to the monocyte count. The increase of systemic
IL-6 was observed in both groups with higher levels after 24
hours in the OPCABG group. Because the monocyte cells
are probably a major source of IL-6, plasma release of this
cytokine has to correlate with the monocyte count. We can-
not demonstrate any statistical difference between the 2
groups in terms of transmyocardial gradient of both cyto-
kines. A lower arteriovenous difference was recorded in
both TNF-a and IL-6 between the 2 groups at T2. We sug-
gest that the release of these inflammatory cytokines is not
affected by the MECC system, aortic crossclamping, or OP-
CABG. Rather, we consider the surgical procedure per se as
the main cause of cytokine release. Moreover, the major sur-
gical stress seems to trigger a lower monocyte activation that
we observed in both groups at the end of the operation. We
cannot explain the smaller, although not significant, release
of cytokines with the MECC system. Perhaps the high per-
forming oxygenator, the centrifugal pump with a low prime,
and the high biocompatibility of the circuit play important
roles in reducing SIRS and myocardial damage. Moreover,
all patients who underwent operation with the MECC sys-
tem received aortic crossclamping with an intrinsic risk of
ischemic/reperfusion injury, which was not observed. Be-
cause SIRS andmyocardial damage are low in those who un-
dergo operation with theMECC system, it can be argued that
MECC may protect the myocardium during the aortic cross-
clamping period. The absence of a statistical difference in
the CS blood lactate release and the transmyocardial gradi-
ent of cytokines after aortic clamp removal or the last anas-
tomosis should indicate a low myocardial injury in the
MECC group. In regard to the hemodilution, we observed
an intraoperative systemic hemodilution in the MECC group
after aortic clamp removal, whereas no difference was ob-
served when the CS hemoglobin was analyzed. It can be
speculated that although the MECC system caused a more
systemic hemodilution than off pump, it was not particularly
severe and therefore did not cause hemodilution in CS blood
compared with OPCABG. It can be argued that oxygenThe Journal of Thoracic and Cdelivery during the aortic crossclamping period is safe and
effective in the MECC system.
There is increasing evidence that OPCABG causes re-
duced CK-MB and troponin serum concentration17,25
when compared with standard CPB. One of our findings in
the present study is the absence of a statistical difference
in TnT and myoglobin release over time, whereas differ-
ences were found in total CK and CK-MB release at the
end of operation only. These differences can be attributed
to a majority of patients who received double ITAs in the
MECC group. Therefore, the regular increase of these myo-
cardial necrosis markers could be attributed to cardiac ma-
nipulation, thoracic artery harvesting, macrosurgical and
microsurgical trauma induced by suction stabilization,
cell-saver blood reinfusion at the end of operation, and
blower-induced air embolization.
CONCLUSIONS
The findings of this study suggest that MECC and OP-
CABG should be considered similar in terms of SIRS, myo-
cardial inflammation and damage, postoperative transfusion,
and early outcome. Thus, considering the current drawback
of the OPCABG procedure, it can be argued that MECC can
be extensively used in all patients with multivessel disease in
whomOPCABG could have more operative risks. More ran-
domized studies are mandatory to confirm the safety and re-
producibility of the MECC system not only in low-risk
patients with coronary disease but also in high-risk patients
with coronary disease, such as those undergoing a repeat
CABG operation or those with moderate or severe myocar-
dial dysfunction that is progressively increasing.
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